FRANKFURT : Positive data on BioNTech and US partner Pfizer Inc's COVID-19 vaccine is an unlikely success for the married couple behind the German biotech firm, who have devoted their lives to harnessing the immune system against cancer.Pfizer said on Monday said its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study.Pfizer and BioNTech are the first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine.
The companies said they have so far found no serious safety concerns and expect to seek US emergency use authorization later this month.From humble roots as the son of a Turkish immigrant working at a Ford factory in Cologne, BioNTech Chief.